Good Documentation Practices (GDP) in Biopharma: Ensuring Compliance & Quality
In the biopharma industry, Good Documentation Practices (GDP) are essential to ensuring product integrity, regulatory compliance, and patient safety.
Proper GDP safeguards the accuracy, reliability, and traceability of critical data throughout the drug development and manufacturing lifecycle.
Why is GDP Crucial in Biopharma?
- Ensures data integrity and regulatory compliance with agencies like the FDA, EMA, and MHRA
- Minimizes risks of errors, deviations, and batch failures in manufacturing and quality control
- Supports audit readiness by maintaining accurate, complete, and retrievable records
- Strengthens cross-functional collaboration between QA, CQV, and regulatory teams
Key GDP Principles in Biopharma:
- Legibility & Accuracy: All records must be clear, readable, and error free
- Traceability & Attribution: Every entry must be signed, dated, and linked to the responsible person
- Real-Time Documentation: Data should be recorded at the time of the activity to prevent gaps
- Compliance with ALCOA+ Standards: All data should be Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.
At Freeman Contracting and Consulting (FCC), we help biopharma companies implement GDP best practices to enhance regulatory compliance, streamline operations, and mitigate risks.
Let’s Work Together to Strengthen GDP in Biopharma!
Contact us to learn how FCC can support your documentation and compliance needs.
https://lnkd.in/dVSZxX6M
#Biopharma #GoodDocumentationPractices #GDP #DataIntegrity #Compliance #CQV #RegulatoryCompliance #QualityAssurance #OperationalExcellence #ALCOA